Effect of Nigella sativa seed administration on prevention of neutropenia during chemotherapy among children with blood cancer

Effect of Nigella sativa seed administration on decreasing of White Blood Cells during chemotherapy among children with ALL

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20191009045035N1

Enrollment

Registered

2019-12-27

Start date

2019-10-23

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute lymphoblastic leukemia. Acute lymphoblastic leukemia [ALL]

Interventions

Intervention 1: Intervention group 1: Under 5 years old in addition to routine medications, receive one capsule containing Nigella sativa daily for one month from Barij Essence Capsules containing Nig

Eligibility

Sex/Gender

All

Age

3 Years to 15 Years

Inclusion criteria

Inclusion criteria: Children aged 3 to 15 yearsWith cancer undergoing chemotherapy No other concomitant diseases

Exclusion criteria

Exclusion criteria: Congenital or acquired immunodeficiency Drug Sensitivity

Design outcomes

Primary

Measure	Time frame
Complete Blood Count. Timepoint: every week. Method of measurement: sampling.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactKiavash Fekri

Shahre-kord University of Medical Sciences

fekri@skums.ac.ir+98 38 3222 0016

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026